TORONTO, ONTARIO -- (Marketwire) -- 01/22/13 -- Biologix Hair Inc. (OTCBB: TGPO) (OTCQB: TGPO) has announced the opening of its Corporate Communications center in Halifax, Nova Scotia to lead the development and dissemination of Biologix marketing and related materials. The center will also serve as an in-house frontline point of contact for general inquiries about the Company and the Biologix Hair Therapy System as well as corporate questions from investors and shareholders. Those with clinician licensing questions are encouraged to contact the Clinician Licensing department in Toronto directly.
The Corporate Communications center will be located in the heart of the city in the Purdy's Wharf office complex, a high tech center with modern conveniences with a reliable, stable communications infrastructure. The area has a surplus of high quality talent available at lower labor costs as compared to other areas and Biologix has contracted with an international employee development group to train local staff. As an added benefit, Halifax lies within the Atlantic time zone (an hour ahead of Eastern), which helps bridge the time difference between Europe and North America, allowing for more efficient communication across the regions.
Janice Matthews has been appointed Vice President of Corporate Communications and will head up the center. Janice brings nearly three decades of experience in communications with a wide variety of clients from around the world. Ms. Matthews said, "I am excited about working with such a talented, forward-looking group of people in this cutting-edge opportunity and intend to put my experience and skills to work immediately to contribute value to the Biologix team. The Communication Center's placement in beautiful Halifax is certainly an added bonus for me."
Ron Holland, Biologix Chairman and CEO, stated, "Janice has strong experience in creating clear marketing and related materials and brings a skill set that will be of real benefit to Biologix as we continue to expand. We are pleased to have her head up our Halifax Communications center."
About Biologix Hair Inc. and Biologix Hair Science Ltd.
Biologix Hair Inc. (Biologix Hair), together with its wholly owned biotechnology subsidiary, Biologix Hair Science Ltd. (BHS), is focused on realizing the full market potential for its patent-pending hair loss formula - Biologix Revive - and its demonstrated ability to prevent and reverse the effects of alopecia, which plagues hundreds of millions worldwide.
Between mid-2004 and mid-2012, more than 30,000 pre-clinical-trial treatments of Biologix Revive were administered to 5,000-plus patients in South America suffering with varying degrees of alopecia, as well as people seeking preventive treatment. The participating treatment clinicians subjectively observed and reported that virtually 100% of preventive care clients continued to retain their healthy hair and an estimated 80-85% of the males and 90-plus% of the females treated for hair regeneration experienced significant regrowth of their own natural hair. And among alopecia areata patients, virtually total hair regrowth was observed in 100% of the cases. To date, no negative side effects have been reported.
Most Popular Stories
- Apple Wants Samsung to Pay $22M for Patent Dispute Legal Bills
- Twitter Coming to Phones Without Internet
- NASA Fellowships, Scholarships Bring Diversity to Workforce
- Dish Network Leads 2013 Top 50 Advertisers List
- Networks Vie for U.S. Hispanic TV Viewers
- Ad Counts Rise in 2013 for Hispanic Magazines
- Jobs Report Brings Cheer As Unemployment Drops to Five-year Low
- Entravision Initiates Quarterly Cash Dividend
- Starbucks Gets Grinchy; No Gingerbread Lattes for Tampa Customers
- Warner Bros. Unleashes 'Hobbit: Desolation of Smaug' Merchandise